About PECA Labs
PECA Labs is a company based in Pittsburgh (United States) founded in 2011. PECA Labs has raised $22.56 million across 12 funding rounds from investors including HHS, Innovation Works and BlueTree Allied Angels. PECA Labs offers products and services including exGraft, exGraft II, OKAPI, MASA Valve, and STEALTH. PECA Labs operates in a competitive market with competitors including Xeltis, Occlutech, Endonovo Therapeutics, Bolder Surgical and Coherex, among others.
- Headquarter Pittsburgh, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Peca Labs, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$22.56 M (USD)
in 12 rounds
-
Latest Funding Round
$2.65 M (USD), Series B
Nov 06, 2025
-
Investors
HHS
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PECA Labs
PECA Labs offers a comprehensive portfolio of products and services, including exGraft, exGraft II, OKAPI, MASA Valve, and STEALTH.
Provides next-generation grafts with radiopaque features for advanced visualization.
Offers customizable, expandable grafts for improved anatomical matching.
Delivers anti-thrombogenic grafts with bio-inert surfaces to reduce complications.
Features polymeric conduit for pulmonary reconstruction in clinical trials.
Includes transcatheter valve with slim delivery for enhanced performance.
People of PECA Labs
Unlock access to complete
Unlock access to complete
Funding Insights of PECA Labs
PECA Labs has successfully raised a total of $22.56M across 12 strategic funding rounds. The most recent funding activity was a Series B round of $2.65 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PECA Labs
PECA Labs has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Innovation Works and BlueTree Allied Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Software, hardware, and life sciences startups are funded and accelerated.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for PECA Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PECA Labs
Investment portfolio details for PECA Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PECA Labs
Detailed financials for PECA Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Peca Labs Comparisons
Peer comparison for PECA Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PECA Labs
PECA Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Xeltis, Occlutech, Endonovo Therapeutics, Bolder Surgical and Coherex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of bioabsorbable synthetic heart valves and vascular grafts
|
|
| Locked | Locked | Locked |
Provider of minimally invasive cardiac devices for congenital heart defects, stroke prevention and heart failure
|
|
| Locked | Locked | Locked |
Bioelectronic devices are developed for regenerative medicine therapies.
|
|
| Locked | Locked | Locked |
Developer of electrosurgical device for pediatric patients
|
|
| Locked | Locked | Locked |
Structural heart disease conditions are addressed with implant devices.
|
Detailed competitors of PECA Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Peca Labs
Complete news archive for PECA Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PECA Labs
PECA Labs was founded in 2011 and raised its 1st funding round 2 years after it was founded.
PECA Labs is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
PECA Labs is a funded company, having raised a total of $22.56M across 12 funding rounds to date.
PECA Labs was founded in 2011 and is based in Pittsburgh, United States. Focus is placed on the medical device sector, specifically pediatric cardiology. Operations involve the creation of synthetic valved conduits, such as the MASA valve made from ePTFE for right ventricular outflow tract reconstruction. A valved RV-PA shunt is also under development to treat hypoplastic left heart syndrome and mitigate risks associated with the Norwood Procedure.
PECA Labs's top competitors include Xeltis, Bolder Surgical and Endonovo Therapeutics.
PECA Labs offers exGraft, exGraft II, OKAPI, MASA Valve, and STEALTH.
PECA Labs has 3 investors. Key investors include HHS, Innovation Works, and BlueTree Allied Angels.